论文部分内容阅读
目的观察糖化血红蛋白(HbAlc)对急性心肌梗死合并2型糖尿病患者预后的影响。方法采用病例回顾性分析的方法,选择2008年6月-2011年6月汤阴县人民医院心内科因急性心肌梗死(均符合WHO急性心肌梗死诊断标准)住院的患者,发病时间<12h、ST段抬高心肌梗死合并2型糖尿病患者272例。按糖化血红蛋白(HbAlc)控制标准分成2组,A组164例(HbAlc≥6.5%),B组106例(HbAlc<6.5%),分析糖化血红蛋白(HbAlc)水平对急性心肌梗死合并2型糖尿病患者预后的影响。结果 A组患者住院期间发生心力衰竭、心源性休克及病死率明高于B组(P<0.05),发生心室颤动及室性心动过速差异无统计学意义(P>0.05)。结论 HbAlc水平升高是影响住院期间发生心力衰竭及病死率的预测因素,因此,2型糖尿病患者严格积极地控制血糖,有助于糖尿病心血管并发症的预防。
Objective To observe the effect of HbAlc on the prognosis of patients with acute myocardial infarction complicated with type 2 diabetes mellitus. Methods The retrospective analysis of cases, choose June 2008 - June 2011 Department of Cardiology, Tangyin People’s Hospital of patients with acute myocardial infarction (both in line with the WHO diagnostic criteria for acute myocardial infarction) patients, the onset time <12h, ST Seventy - two patients with elevated myocardial infarction and type 2 diabetes mellitus. According to the control standard of HbAlc, the patients were divided into two groups: 164 patients in group A (HbAlc≥6.5%) and 106 patients in group B (HbAlc <6.5%). The levels of HbAlc in patients with acute myocardial infarction complicated with type 2 diabetes The impact of prognosis. Results A group of patients with heart failure during hospitalization, cardiogenic shock and mortality was significantly higher than the B group (P <0.05), the occurrence of ventricular fibrillation and ventricular tachycardia was no significant difference (P> 0.05). Conclusions HbA1c level is a predictor of heart failure and mortality during hospitalization. Therefore, patients with type 2 diabetes strictly and positively control blood sugar, which is helpful to the prevention of cardiovascular complications of diabetes.